STOCK TITAN

[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) disclosed an insider transaction by a director on 10/23/2025. The filing reports the acquisition of 1,057 shares of common stock via the settlement of restricted stock units (Transaction Code M). Following the transaction, the reporting person directly owns 6,315 common shares and holds 2,115 restricted stock units.

The RSUs vest in four equal installments of 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026. The RSU settlement carried a stated price of $0 for the underlying common shares, consistent with equity award vesting mechanics.

USANA Health Sciences (USNA) ha comunicato una operazione di insider trading da parte di un amministratore il 23/10/2025. La dichiarazione riporta l'acquisizione di 1.057 azioni ordinarie tramite la liquidazione di unità di azioni vincolate (Codice di Transazione M). Dopo la transazione, la persona che segnala possiede direttamente 6.315 azioni ordinarie e detiene 2.115 unità di azioni vincolate.

Le RSU maturano in quattro rate uguali del 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026. Il regolamento delle RSU ha fissato un prezzo dichiarato di $0 per le azioni ordinarie sottostanti, in linea con i meccanismi di vesting delle stock award.

USANA Health Sciences (USNA) divulgó una operación interna por parte de un director el 23/10/2025. El registro reporta la adquisición de 1.057 acciones comunes mediante la liquidación de unidades de acciones restringidas (Código de Transacción M). Tras la transacción, la persona informante posee directamente 6.315 acciones comunes y mantiene 2.115 unidades de acciones restringidas.

Las RSU vencen en cuatro cuotas iguales del 25% en 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026. La liquidación de RSU tuvo un precio declarado de $0 para las acciones subyacentes, conforme con la mecánica de vesting de las asignaciones de acciones.

USANA Health Sciences (USNA) 이사는 2025년 10월 23일에 내부자 거래를 공시했다. 신고서는 1,057주 일반 주식의 취득을 제한 주식 단위(RSU) 정산을 통해 보고하며(거래 코드 M). 거래 후 보고자는 직접 6,315주 일반 주식을 보유하고 있으며 2,115주 제한 주식 단위를 보유한다.

RSU는 4회에 걸쳐 동일한 25%씩 귀속되며 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 각각 귀속된다. RSU 정산은 기초 일반 주식에 대해 $0의 명시된 가격을 부여하며, 이는 주식 보상 vesting 메커니즘과 일치한다.

USANA Health Sciences (USNA) a divulgué une opération interne par un administrateur le 23/10/2025. Le dossier indique l'acquisition de 1 057 actions ordinaires par règlement d'unités d'actions restreintes (Code de transaction M). Suite à l'opération, la personne déclarant détient directement 6 315 actions ordinaires et détient 2 115 unités d'actions restreintes.

Les RSU vestent en quatre versements égaux de 25% les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026. Le règlement des RSU a fixé un prix déclaré de $0 pour les actions ordinaires sous-jacentes, conforme au mécanisme de vesting des attributions d'actions.

USANA Health Sciences (USNA) hat eine Insider-Transaktion eines Direktors am 23.10.2025 offengelegt. Die Einreichung berichtet den Erwerb von 1.057 Stammaktien durch Begleichung von Restricted Stock Units (Transaktionscode M). Nach der Transaktion besitzt die meldende Person direkt 6.315 Stammaktien und hält 2.115 RSUs.

Die RSUs vesten in vier gleichen Raten von je 25% am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026. Die RSU-Abrechnung wies einen festgelegten Preis von $0 für die zugrunde liegenden Stammaktien aus, entsprechend den Vesting-Mechanismen von Aktienzuteilungen.

USANA Health Sciences (USNA) كشفت عن صفقة داخلية من قبل مدير بتاريخ 23/10/2025. يُظهر الإيداع اكتساب 1,057 سهماً عاديّاً عبر تسوية وحدات أسهم مقيدة (رمز المعاملة M). بعد الصفقة، يمتلك الشخص المُبلغ عنها مباشرةً 6,315 سهماً عاديّاً ويحتفظ بـ 2,115 وحدة أسهم مقيدة.

تتساق RSUs على أربع دفعات متساوية بنسبة 25% في 24 يوليو 2025، و23 أكتوبر 2025، و22 يناير 2026، و23 أبريل 2026. تَسوية RSU تحمل سعرًا مُعلنًا قدره $0 للأوراق المالية الأساسية، بما يتماشى مع آليات تقادم المنح بالنِسب.

Positive
  • None.
Negative
  • None.

USANA Health Sciences (USNA) ha comunicato una operazione di insider trading da parte di un amministratore il 23/10/2025. La dichiarazione riporta l'acquisizione di 1.057 azioni ordinarie tramite la liquidazione di unità di azioni vincolate (Codice di Transazione M). Dopo la transazione, la persona che segnala possiede direttamente 6.315 azioni ordinarie e detiene 2.115 unità di azioni vincolate.

Le RSU maturano in quattro rate uguali del 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026. Il regolamento delle RSU ha fissato un prezzo dichiarato di $0 per le azioni ordinarie sottostanti, in linea con i meccanismi di vesting delle stock award.

USANA Health Sciences (USNA) divulgó una operación interna por parte de un director el 23/10/2025. El registro reporta la adquisición de 1.057 acciones comunes mediante la liquidación de unidades de acciones restringidas (Código de Transacción M). Tras la transacción, la persona informante posee directamente 6.315 acciones comunes y mantiene 2.115 unidades de acciones restringidas.

Las RSU vencen en cuatro cuotas iguales del 25% en 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026. La liquidación de RSU tuvo un precio declarado de $0 para las acciones subyacentes, conforme con la mecánica de vesting de las asignaciones de acciones.

USANA Health Sciences (USNA) 이사는 2025년 10월 23일에 내부자 거래를 공시했다. 신고서는 1,057주 일반 주식의 취득을 제한 주식 단위(RSU) 정산을 통해 보고하며(거래 코드 M). 거래 후 보고자는 직접 6,315주 일반 주식을 보유하고 있으며 2,115주 제한 주식 단위를 보유한다.

RSU는 4회에 걸쳐 동일한 25%씩 귀속되며 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 각각 귀속된다. RSU 정산은 기초 일반 주식에 대해 $0의 명시된 가격을 부여하며, 이는 주식 보상 vesting 메커니즘과 일치한다.

USANA Health Sciences (USNA) a divulgué une opération interne par un administrateur le 23/10/2025. Le dossier indique l'acquisition de 1 057 actions ordinaires par règlement d'unités d'actions restreintes (Code de transaction M). Suite à l'opération, la personne déclarant détient directement 6 315 actions ordinaires et détient 2 115 unités d'actions restreintes.

Les RSU vestent en quatre versements égaux de 25% les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026. Le règlement des RSU a fixé un prix déclaré de $0 pour les actions ordinaires sous-jacentes, conforme au mécanisme de vesting des attributions d'actions.

USANA Health Sciences (USNA) hat eine Insider-Transaktion eines Direktors am 23.10.2025 offengelegt. Die Einreichung berichtet den Erwerb von 1.057 Stammaktien durch Begleichung von Restricted Stock Units (Transaktionscode M). Nach der Transaktion besitzt die meldende Person direkt 6.315 Stammaktien und hält 2.115 RSUs.

Die RSUs vesten in vier gleichen Raten von je 25% am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026. Die RSU-Abrechnung wies einen festgelegten Preis von $0 für die zugrunde liegenden Stammaktien aus, entsprechend den Vesting-Mechanismen von Aktienzuteilungen.

USANA Health Sciences (USNA) كشفت عن صفقة داخلية من قبل مدير بتاريخ 23/10/2025. يُظهر الإيداع اكتساب 1,057 سهماً عاديّاً عبر تسوية وحدات أسهم مقيدة (رمز المعاملة M). بعد الصفقة، يمتلك الشخص المُبلغ عنها مباشرةً 6,315 سهماً عاديّاً ويحتفظ بـ 2,115 وحدة أسهم مقيدة.

تتساق RSUs على أربع دفعات متساوية بنسبة 25% في 24 يوليو 2025، و23 أكتوبر 2025، و22 يناير 2026، و23 أبريل 2026. تَسوية RSU تحمل سعرًا مُعلنًا قدره $0 للأوراق المالية الأساسية، بما يتماشى مع آليات تقادم المنح بالنِسب.

USANA Health Sciences (USNA)2025-10-23 披露了一起由董事进行的内部交易。该披露记录通过结算受限股票单位(RSU)获取 1,057 股普通股(交易代码 M)。交易后,报告人直接拥有 6,315 股普通股,并持有 2,115 份受限股票单位

RSU 将分四次等额 vesting,每次占 25%,分别在 2025-07-242025-10-232026-01-222026-04-23 到期归属。RSU 结算对基础普通股设定的价格为 $0,与股票奖励归属机制一致。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fleming John Turman

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/23/2025 M 1,057 A (1) 6,315 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/23/2025 M 1,057 (2) (2) Common Stock 1,057 $0 2,115 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did USNA report on this Form 4?

A director settled restricted stock units (Code M), acquiring 1,057 common shares on 10/23/2025.

How many USNA shares does the reporting person own after the transaction?

Direct beneficial ownership is 6,315 common shares after the transaction.

How many USNA RSUs does the insider still hold?

The filing shows 2,115 restricted stock units beneficially owned after the reported transaction.

What is the vesting schedule for the USNA RSUs?

RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Was there a purchase price for the 1,057 USNA shares acquired?

The RSU settlement lists a price of $0 for the underlying common stock, typical for vesting equity awards.

What relationship does the reporting person have with USANA (USNA)?

The reporting person is a Director of USANA Health Sciences.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

358.31M
10.40M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY